- Home
- HLP vs RENB Comparison
HLP vs RENB Comparison
Compare HLP & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- RENB
- Stock Information
- Founded
- HLP 2021
- RENB 2011
- Country
- HLP China
- RENB United States
- Employees
- HLP N/A
- RENB N/A
- Industry
- HLP Industrial Machinery/Components
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- HLP Industrials
- RENB Health Care
- Exchange
- HLP Nasdaq
- RENB Nasdaq
- Market Cap
- HLP 52.1M
- RENB 57.7M
- IPO Year
- HLP 2023
- RENB N/A
- Fundamental
- Price
- HLP $0.69
- RENB $0.25
- Analyst Decision
- HLP
- RENB
- Analyst Count
- HLP 0
- RENB 0
- Target Price
- HLP N/A
- RENB N/A
- AVG Volume (30 Days)
- HLP 207.2K
- RENB 879.6K
- Earning Date
- HLP 09-18-2025
- RENB 10-09-2025
- Dividend Yield
- HLP N/A
- RENB N/A
- EPS Growth
- HLP N/A
- RENB N/A
- EPS
- HLP N/A
- RENB N/A
- Revenue
- HLP $14,105,620.00
- RENB N/A
- Revenue This Year
- HLP N/A
- RENB N/A
- Revenue Next Year
- HLP N/A
- RENB N/A
- P/E Ratio
- HLP N/A
- RENB N/A
- Revenue Growth
- HLP N/A
- RENB N/A
- 52 Week Low
- HLP $0.61
- RENB $0.22
- 52 Week High
- HLP $2.13
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- HLP 48.54
- RENB 51.08
- Support Level
- HLP $0.66
- RENB $0.22
- Resistance Level
- HLP $0.68
- RENB $0.27
- Average True Range (ATR)
- HLP 0.05
- RENB 0.02
- MACD
- HLP 0.01
- RENB 0.00
- Stochastic Oscillator
- HLP 40.08
- RENB 83.33
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.